Gang Wang1, Jia-Hui Chen1, Yong Qiang1, Dong-Zhi Wang1, Zhong Chen1. 1. Gang Wang, Yong Qiang, Dong-Zhi Wang, Zhong Chen, Department of General Surgery, Medical School of Nantong University, Nantong 226000, Jiangsu Province, China.
Abstract
AIM: To investigate the role of signal transduction and activation of transcription 4 (STAT4) in the development and progression of human hepatocellular carcinoma (HCC). METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis B virus (HBV)-related HCC. The level of STAT4 in 90 HCC patients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis B surface antigen level in HCC patients. The data were statistically analyzed using SPSS. Furthermore, siRNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. Based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells. RESULTS: STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression (r = 0.851; P < 0.05) and positively correlated with maximal tumor size (P < 0.05), HBV (P = 0.012) and histological grade (P < 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCC patients expressing low and high levels of STAT4 and Ki67 (P < 0.05). Based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCC patients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with siRNA targeting STAT4 inhibited cell proliferation. CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.
AIM: To investigate the role of signal transduction and activation of transcription 4 (STAT4) in the development and progression of humanhepatocellular carcinoma (HCC). METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis B virus (HBV)-related HCC. The level of STAT4 in 90 HCCpatients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis B surface antigen level in HCCpatients. The data were statistically analyzed using SPSS. Furthermore, siRNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. Based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells. RESULTS:STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression (r = 0.851; P < 0.05) and positively correlated with maximal tumor size (P < 0.05), HBV (P = 0.012) and histological grade (P < 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCCpatients expressing low and high levels of STAT4 and Ki67 (P < 0.05). Based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCCpatients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with siRNA targeting STAT4 inhibited cell proliferation. CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.
Entities:
Keywords:
Hepatocellular carcinoma; Prognosis; Proliferation; Signal transduction and activation of transcription 4
Authors: Zuyao Ni; Wei Lou; Soo Ok Lee; Rajiv Dhir; Fernando DeMiguel; Jennifer Rubin Grandis; Allen C Gao Journal: J Urol Date: 2002-04 Impact factor: 7.450
Authors: Xiu-Da Shen; Bibo Ke; Yuan Zhai; Feng Gao; Dean Anselmo; Charles R Lassman; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Hepatology Date: 2003-02 Impact factor: 17.425
Authors: Jürgen Siebler; Stefan Wirtz; Sonja Klein; Martina Protschka; Manfred Blessing; Peter R Galle; Markus F Neurath Journal: Hepatology Date: 2003-12 Impact factor: 17.425
Authors: Oliver D Mrowczynski; Achuthamangalam B Madhankumar; Jeffrey M Sundstrom; Yuanjun Zhao; Yuka Imamura Kawasawa; Becky Slagle-Webb; Christine Mau; Russell A Payne; Elias B Rizk; Brad E Zacharia; James R Connor Journal: Oncotarget Date: 2018-11-16